Hayek Kallen Investment Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.89M Buy
+36,391
New +$8.48M 2.9% 8
2025
Q4
Sell
-36,831
Closed -$6.83M 131
2025
Q3
$6.83M Sell
36,831
-137
-0.4% -$23.5K 2.16% 13
2025
Q2
$5.65M Buy
36,968
+319
+0.9% +$49K 1.92% 13
2025
Q1
$6.08M Sell
36,649
-428
-1% -$67K 2.24% 13
2024
Q4
$5.36M Sell
37,077
-13
-0% -$2.02K 1.95% 14
2024
Q3
$6.01M Sell
37,090
-330
-0.9% -$52.6K 2.13% 14
2024
Q2
$5.47M Buy
37,420
+1,007
+3% +$150K 2.04% 14
2024
Q1
$5.76M Buy
36,413
+247
+0.7% +$39.3K 2.21% 13
2023
Q4
$5.67M Sell
36,166
-53
-0.1% -$8.13K 2.37% 9
2023
Q3
$5.64M Sell
36,219
-33
-0.1% -$5.45K 2.53% 8
2023
Q2
$6M Buy
36,252
+1,510
+4% +$244K 2.55% 9
2023
Q1
$5.38M Sell
34,742
-715
-2% -$115K 2.44% 10
2022
Q4
$6.26M Sell
35,457
-510
-1% -$88.1K 2.89% 8
2022
Q3
$5.88M Buy
35,967
+108
+0.3% +$18.3K 2.76% 8
2022
Q2
$6.37M Sell
35,859
-275
-0.8% -$49K 2.77% 9
2022
Q1
$6.4M Sell
36,134
-269
-0.7% -$45.8K 2.37% 11
2021
Q4
$6.23M Buy
36,403
+2,922
+9% +$478K 2.22% 11
2021
Q3
$5.41M Sell
33,481
-294
-0.9% -$50.2K 2.47% 10
2021
Q2
$5.56M Buy
33,775
+130
+0.4% +$21.5K 2.34% 12
2021
Q1
$5.53M Sell
33,645
-84
-0.2% -$13.6K 2.49% 12
2020
Q4
$5.31M Sell
33,729
-90
-0.3% -$13.3K 2.57% 11
2020
Q3
$5.04M Sell
33,819
-595
-2% -$88K 2.81% 9
2020
Q2
$4.84M Sell
34,414
-330
-0.9% -$48.1K 2.74% 9
2020
Q1
$4.56M Sell
34,744
-440
-1% -$62.4K 3.06% 8
2019
Q4
$5.13M Sell
35,184
-546
-2% -$74.1K 2.96% 9
2019
Q3
$4.62M Sell
35,730
-1,288
-3% -$170K 2.89% 9
2019
Q2
$5.16M Sell
37,018
-711
-2% -$98.4K 3.27% 9
2019
Q1
$5.27M Sell
37,729
-396
-1% -$53K 3.42% 8
2018
Q4
$4.92M Sell
38,125
-357
-0.9% -$49.8K 3.53% 6
2018
Q3
$5.32M Sell
38,482
-466
-1% -$61.9K 3.4% 7
2018
Q2
$4.73M Sell
38,948
-443
-1% -$55.3K 3.26% 8
2018
Q1
$5.05M Sell
39,391
-42
-0.1% -$5.68K 3.5% 6
2017
Q4
$5.51M Sell
39,433
-617
-2% -$85.9K 3.61% 6
2017
Q3
$5.21M Sell
40,050
-1,372
-3% -$182K 3.57% 5
2017
Q2
$5.48M Sell
41,422
-1,151
-3% -$147K 3.7% 4
2017
Q1
$5.3M Sell
42,573
-101
-0.2% -$12.1K 3.68% 4
2016
Q4
$4.92M Sell
42,674
-1,079
-2% -$125K 3.58% 6
2016
Q3
$5.17M Sell
43,753
-441
-1% -$53.5K 3.69% 6
2016
Q2
$5.36M Sell
44,194
-1,776
-4% -$202K 3.85% 5
2016
Q1
$4.97M Sell
45,970
-662
-1% -$68.5K 3.68% 6
2015
Q4
$4.79M Sell
46,632
-1,265
-3% -$127K 3.67% 7
2015
Q3
$4.47M Buy
47,897
+376
+0.8% +$36.4K 3.48% 7
2015
Q2
$4.63M Buy
47,521
+146
+0.3% +$14.6K 3.46% 9
2015
Q1
$4.77M Sell
47,375
-285
-0.6% -$29K 3.51% 9
2014
Q4
$4.98M Sell
47,660
-1,660
-3% -$175K 3.68% 6
2014
Q3
$5.26M Sell
49,320
-3,323
-6% -$345K 4% 6
2014
Q2
$5.51M Sell
52,643
-1,189
-2% -$120K 4.16% 4
2014
Q1
$5.29M Sell
53,832
-1,886
-3% -$175K 4.22% 4
2013
Q4
$5.1M Sell
55,718
-4,187
-7% -$386K 3.97% 4
2013
Q3
$5.19M Sell
59,905
-2,762
-4% -$248K 4.29% 3
2013
Q2
$5.38M Buy
+62,667
New +$5.32M 4.55% 3

Other funds holding JNJ

Hayek Kallen Investment Management's JNJ Position: Q1 2026 in Review

Hayek Kallen Investment Management opened a new position in Johnson & Johnson (JNJ) in Q1 2026: 36,391 shares worth $8.89M. The stake represents 2.9% of the portfolio and ranks #8 among its holdings. This is a return to the name: Hayek Kallen Investment Management previously reported a position in JNJ as recently as Q3 2025.

Hayek Kallen Investment Management first reported a position in JNJ in Q2 2013 and has held it in 51 quarters since. 4,627 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Hayek Kallen Investment Management held 36,391 shares of Johnson & Johnson worth $8.89M as of Q1 2026.
  • Johnson & Johnson was a new Hayek Kallen Investment Management position in Q1 2026.
  • Johnson & Johnson made up 2.9% of Hayek Kallen Investment Management's portfolio in Q1 2026, its #8 holding.
  • Hayek Kallen Investment Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 51 quarters since.
  • 4,627 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Hayek Kallen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.